| Baseline | After 8–10# CRT | % Change | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | pTRG | Stage | Clinical | Tumour | Blood | T:B | Tumour | Tumour | % of | Tumour | Blood | T:B | Tumour | Tumour | % of | Tumour | Blood | T:B | Tumour | Tumour | % of |
Number | AJCC | Â | Response | SUV | SUV | SUV | hypoxic | ROI | tumour | SUV | SUV | SUV | hypoxic | ROI | tumour | SUV | SUV | SUV | hypoxic | ROI | tumour |
 |  |  |  | max | max | max | volume | volume | volume | max | max | max | volume | volume | volume | max | max | max | volume | volume | volume |
 |  |  |  |  |  |  | cm3 | cm3 | i.e. hypoxic |  |  |  | cm3 | cm3 | i.e. hypoxic |  |  |  |  |  | i.e. hypoxic |
P1 | 1 | ypT3N2 | Poor | 2.09 | 1.32 | 1.58 | 0.39 | 80.41 | 0.48 | 1.79 | 1.13 | 1.58 | 1.27 | 88.60 | 1.43 | −14.35 | −14.65 | 0.34 | 225.99 | 10.19 | 195.85 |
P2 | 1 | ypT3N1 | Good | 5.19 | 1.45 | 3.57 | 8.41 | 23.20 | 36.25 | 4.97 | 1.56 | 3.18 | 3.99 | 26.85 | 14.85 | −4.31 | 7.44 | −10.94 | −52.62 | 15.70 | −59.05 |
P3 | 3 | ypT3N0 | Poor | 3.39 | 1.76 | 1.93 | 5.31 | 179.77 | 2.95 | 2.24 | 1.44 | 1.56 | 0.59 | 86.53 | 0.68 | −33.78 | −18.14 | −19.11 | −88.94 | −51.87 | −77.02 |
P4 | 2 | ypT3N0 | Poor | 4.16 | 1.57 | 2.66 | 6.58 | 30.66 | 21.45 | 2.70 | 1.56 | 1.73 | 0.76 | 13.35 | 5.68 | −35.10 | −0.11 | −35.02 | −88.48 | −56.46 | −73.53 |
P5 | NR | N/A | Good | 4.98 | 1.31 | 3.79 | 14.38 | 62.59 | 22.97 | 1.78 | 1.62 | 1.10 | 0.00 | 55.79 | 0.00 | −64.17 | 23.60 | −71.01 | −100.00 | −10.86 | −100.00 |
P6 | NR | N/A | Poor | 3.38 | 1.50 | 2.26 | 6.06 | 18.80 | 32.25 | - | - | - | - | - | - | - | - | - | - | - | - |
P7 | NR | N/A | Good | 3.52 | 1.06 | 3.33 | 1.17 | 4.16 | 28.24 | 2.44 | 1.14 | 2.14 | 0.51 | 0.93 | 55.26 | −30.54 | 7.81 | −35.58 | −56.25 | −77.65 | 95.72 |
P8 | 2 | ypT3N2 | Poor | 5.31 | 1.19 | 4.45 | 10.66 | 28.43 | 37.49 | 2.49 | 1.46 | 1.71 | 1.91 | 28.61 | 6.68 | −53.14 | 22.10 | −61.62 | −82.08 | 0.60 | −82.19 |
P9 | 2 | ypT3N1 | Poor | 3.04 | 1.35 | 2.25 | 2.08 | 15.06 | 13.80 | 1.82 | 1.14 | 1.60 | 1.30 | 13.96 | 9.28 | −39.97 | −15.35 | −29.09 | −37.64 | −7.31 | −32.73 |
P10 | 0 | ypT0N1 | Good | – | – | – | – | – | - | – | – | – | – | – | - | – | – | – | – | – | – |
P11 | 2 | ypT3N0 | Good* | 1.94 | 1.22 | 1.58 | 2.15 | 10.98 | 19.61 | 2.40 | 1.49 | 1.61 | 0.15 | 5.23 | 2.80 | 23.87 | 21.73 | 1.76 | 0.00 | −52.34 | 0.00 |
Median |  |  |  | 3.45 | 1.34 | 2.46 | 5.68 | 25.82 | 22.21 | 2.40 | 1.46 | 1.61 | 0.76 | 26.85 | 5.68 | −33.78 | 7.44 | −29.09 | −56.25 | −10.86 | −59.05 |
IQR | Â | Â | Â | 1.65 | 0.24 | 1.50 | 5.86 | 38.61 | 16.00 | 0.67 | 0.42 | 0.14 | 0.78 | 42.44 | 7.85 | 25.62 | 36.37 | 24.64 | 50.83 | 52.94 | 77.02 |